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Abstract 
Searching for biomarkers has been a chief pursuit of the field of psychiatry. Toward 
this end, studies have catalogued candidate resting-state biomarkers in nearly all 
forms of mental disorder. However, it is becoming increasingly clear that these 
biomarkers lack specificity, limiting their capacity to yield clinical impact. We discuss 
three avenues of research that are overcoming this limitation: (i) the adoption of 
transdiagnostic research designs, which involve studying and explicitly comparing 
multiple disorders from distinct diagnostic axes of psychiatry; (ii) dimensional models 
of psychopathology that map the full spectrum of symptomatology and that cut across 
traditional disorder boundaries; and (iii) modeling individuals’ unique functional 
connectomes throughout development. We provide a framework for tying these 
subfields together that draws on tools from machine learning and network science. 
 
  
Introduction 
Precision medicine refers to the idea that diagnosis and treatment strategies for disease 
processes are optimized when an individual’s unique biology is taken into account [1,2]. 
Critical to this paradigm is the biomarker, which is broadly defined as any biological 
signature that provides an objective indication of an individual’s disease status and that 
ideally predicts clinical outcomes [3]. In recent decades, detecting biomarkers of 
psychiatric disorders has become a central goal for neuroimaging research as a means 
to drive psychiatry towards precision medicine [1]. To this end, a large body of literature 
has emerged using resting-state functional magnetic resonance imaging (rs-fMRI) to 
characterize the brain dysfunction accompanying psychiatric conditions [4]. However, a 
combination of high symptomatic and biological heterogeneity within disorders as well 
as comorbidity amongst disorders [5,6] has resulted in a lack of disorder specificity in 
candidate biomarkers. This lack of specificity has rendered the field unable to translate 
knowledge reliably into clinical practice [7]. Here, we discuss three recent developments 
in rs-fMRI research that hold promise for improving our capacity to generate biomarkers 
for mental health. First, we highlight a shift in focus from studying single disorders in 
isolation to transdiagnostic paradigms that examine multiple disorders in a single study. 
Second, we discuss insights from studies that take a dimensional, as opposed to 
categorical, approach to measuring psychopathology. Third, we briefly review how 
understanding the developing functional connectome is providing new directions into 
studying brain dysfunction. Finally, we provide a framework for tying these three areas 
of research together drawing on machine learning models of normative 
neurodevelopment [8,9] and tools from network science [10,11]. 
 
1. A shift toward transdiagnostic research 
The standard paradigm for biomarker detection in psychiatry is the case-control 
design, a categorical approach wherein case refers to a group of individuals 
experiencing a given mental disorder, and control refers to a group of individuals not 
experiencing the disorder [12]. Typically, individuals in the control group are selected 
because they are not experiencing any mental disorder (i.e., healthy control), hence any 
observed group differences are attributed to the disease process. Since the inception 
of the rs-fMRI paradigm [13], case-control rs-fMRI studies have been conducted in 
almost every major disorder described by psychiatric nosologies (e.g., DSM-5, ICD-11). 
However, within a single study, the case-control paradigm is typically applied to a 
single disorder; rarely are multiple disorders studied concurrently. Consequently, 
recent meta-analytic work has revealed that many of the field’s candidate biomarkers 
lack disorder specificity. Sha et al. [14] examined 182 rs-fMRI studies spanning 
attention deficit hyperactivity disorder (ADHD), autism spectrum disorder, bipolar 
disorder, depression, obsessive-compulsive disorder (OCD), post-traumatic stress 
disorder, and schizophrenia (as well as several neurological disorders) and found that 
dysfunction in the default-mode, sensorimotor, fronto-parietal, and subcortical systems 
was common to all disorders. This result challenges the idea that large-scale 
dysconnectivity between these systems represents a disorder-specific biomarker (see 
Dong et al. [15] for a recent example in schizophrenia). Instead, this result 
demonstrates that in order to attain specificity, the field needs to transition to 
transdiagnostic designs, wherein multiple disorders are examined concurrently, and 
differential diagnostic sensitivity can be directly assessed. 
 
One candidate biomarker where progress toward disorder specificity has shown 
recent promise is dysfunction in the frontostriatal circuits [16]. Frontostriatal circuits are 
a set of parallel circuits that topographically connect different regions of the frontal 
cortex to different subregions of the striatum [17,18]. Using a combination of resting-
state activity within the striatum, as well as intra- and extra- striatal connectivity, Li et 
al. [16] trained a support vector machine (SVM) to separate schizophrenia patients from 
healthy controls. Then, the authors took the distance between each individual and the 
separating SVM hyperplane as an index for frontostriatal abnormality (FSA). Next, they 
compared FSA scores from individuals with schizophrenia, bipolar disorder, 
depression, OCD, and ADHD against healthy controls and found that only the 
schizophrenia and bipolar groups showed significant differences in FSA scores, with 
differences being greater for schizophrenia relative to bipolar. This pattern of results 
suggests that the author’s SVM learned multivariate patterns of frontostriatal 
dysfunction that selectively separated schizophrenia and bipolar from healthy controls. 
However, such selectivity does not imply that disorder-specific frontostriatal 
dysfunction is absent in other disorders (e.g., OCD [19,20]). Li et al. trained their SVM 
to separate schizophrenia and healthy controls, and then used that model to generate 
FSA scores for other disorder groups. Thus, a different SVM could be trained to 
separate OCD from healthy controls and to test for selective frontostriatal dysfunction 
in OCD. Further, this OCD-trained SVM could be compared to the schizophrenia-
trained SVM to characterize patterns of frontostriatal dysfunction that support 
differential diagnosis. 
 
2. Dimensions of psychopathology 
While transdiagnostic case-control designs may assist in identifying which biomarkers 
are disorder-specific or disorder-general, these study designs remain focused on the 
group-level signatures revealed by comparing healthy individuals with those that meet 
criteria for a mental disorder. Consequently, they fail to capture subclinical variation in 
symptomatology that is important for understanding the link between brain dysfunction 
and psychiatry [21,22]. In response to this limitation, rs-fMRI studies have begun taking 
an explicitly dimensional approach, wherein the full range of variation -- normal, 
subclinical, and abnormal -- in symptomatology and brain function is characterized.  
 
Recent rs-fMRI studies deploying dimensional models have varied in terms of 
the number and scope of the estimated dimensions of psychopathology. On the one 
hand, some studies have aimed to quantify dimensions of psychopathology that cut 
across a broad range of diagnostic entities, with a view to teasing apart which 
biomarkers are unique to, or common across, most diagnostic axes of psychiatry. 
These studies have often drawn on the idea of the p-factor [23,24], a statistical concept 
that posits that the endorsement of any psychiatric symptom increases the probability 
of endorsing any other symptom (so-called overall psychopathology). Studies typically 
estimate the p-factor alongside multiple specific dimensions of psychopathology (e.g., 
depression, psychosis) in a hierarchical fashion, rendering the specific dimensions 
orthogonal to each other and the p-factor. This model structure allows researchers to 
uncover both disorder-general and disorder-specific biomarkers. On the other hand, 
some studies have focused on decomposing a single diagnostic axis of psychiatry 
(e.g., psychosis) into multiple subcomponents (e.g., positive and negative psychosis 
dimensions), aiming instead to discover multiple distinct biomarkers within select 
disorders. 
 
At the multi-diagnosis level, recent studies by Elliot et al. [25] and Kebets et al. 
[26] found that greater scores on the p-factor were associated with hypo-connectivity 
within sensory and somatomotor systems, as well as with hyper-connectivity between 
these systems and the executive systems. These results point toward a disorder-
general biomarker of dysconnectivity between lower- and higher-order systems in the 
cortical hierarchy. Notably, convergence between these studies was present despite 
the use of distinct statistical methods (for a review of the methods see Kaczkurkin et al. 
[27]). Briefly, Elliot et al. modeled latent psychopathology dimensions independently of 
the rs-fMRI data (i.e., a so-called single-view approach), and then related the p-factor 
to functional connectivity. By contrast, Kebets et al. deployed a multi-view approach 
that jointly estimated latent dimensions of psychopathology and functional connectivity 
in a single model and labeled one of their dimensions as a p-factor post hoc. However, 
another multi-view study by Xia et al. [28] found instead that dysconnectivity between 
the higher-order default mode and executive systems was common across dimensions 
of mood, psychosis, fear, and externalizing behavior. That Xia et al.’s results implicated 
the higher-order cortical systems while Kebets et al. and Elliot et al.’s results implicated 
the lower-order cortical systems may be due to the fact that Xia et al. did not find a p-
factor in their data. Instead, Xia et al. derived disorder-general biomarkers by 
examining the spatial correspondence between patterns of dysconnectivity observed 
for their specific dimensions. This pattern of results suggests that the presence or 
absence of a p-factor impacts the ensuing biomarkers. Indeed, how to best model 
broad dimensions of psychopathology that span multiple diagnostic categories 
remains open to debate in the field [29]. 
 
 At the single-diagnosis level, dimensional models have been used to uncover 
differences in functional connectivity across subdimensions of specific forms of 
psychopathology. Sabaroedin et al. [30] examined the extent to which normal and 
subclinical variation in negative and positive psychosis-like experiences (PLE) tracked 
differences in resting-state frontostriatal connectivity in a large population cohort. 
Convergent with previous literature in schizophrenia, greater positive PLEs were 
associated with reduced connectivity between the dorsal striatum and prefrontal 
cortex, demonstrating that frontostriatal dysfunction in schizophrenia may generalize to 
subclinical levels of psychotic phenomenology. Taking a dimensional and 
transdiagnostic approach, Parkes et al. [19] examined frontostriatal dysfunction in 
individuals with OCD and individuals with gambling disorder (GD). The authors 
examined whether dimensional measures of impulsivity and compulsivity, two 
constructs with joint relevance to OCD and GD, tracked variation in resting-state 
effective connectivity in frontostriatal circuits. Compared to pairwise case-control and 
case-case comparisons, Parkes et al. found that inter-individual differences in 
compulsivity better explained frontostriatal dysconnectivity when patients and controls 
were pooled into a single group. These studies show that splitting specific dimensions 
of psychopathology into subdimensions reveal addition insights in brain dysfunction 
and, together with the broad multi-diagnosis studies, highlight the importance of 
considering dimensional models of psychopathology at multiple scales of specificity. 
 
3. Modeling the connectome throughout development 
In addition to transdiagnostic and dimensional designs, linking mental disorder to rs-
fMRI has also been facilitated by progress in modeling the connectome throughout 
development. In a connectome identifiability [31] study (Box 1), Kaufmann et al. [32] 
showed that individuals’ whole-brain connectomes became increasingly distinct from 
one another throughout childhood and adolescence, demonstrating that the whole-
brain connectome encodes individualized fingerprints that emerge with age. Critically, 
individuals with greater scores on the p-factor showed reduced connectome 
distinctiveness compared to healthy individuals, indicating that disruptions to the 
formation of these fingerprints is relevant to mental health. Subsequent longitudinal 
work showed that whole-brain connectomes could be used to identify participants 
across time intervals of several months and up to 2 years [33,34], demonstrating that 
connectome fingerprints are stable over long periods.  
 
 The above studies have also illustrated that different brain systems have a 
differential impact on identifiability. Horien et al. [33] and Miranda-Dominguez et al. [34] 
each found, across multiple datasets, that higher-order executive systems offered 
higher identifiability than lower-order sensory and motor systems; the latter only 
outperformed subcortical systems [33]. This differential system effect remained 
throughout childhood and adolescence, and into adulthood [32,35]. Thus, whereas 
higher-order systems develop into increasingly individualized functional fingerprints, 
lower-order systems remain stable and more homogenous across individuals. 
Critically, Kaufmann et al. [32] found that the reduced connectome distinctiveness 
associated with greater p-factor scores was more pronounced in the executive 
systems, suggesting that disruptions to an individual’s higher-order functional 
fingerprint is indicative of mental disorder. 
 
The above neurodevelopmental work stands in contrast to the studies 
demonstrating that greater p-factor scores were predominantly associated with 
dysconnectivity centered on the lower-order sensory and somatomotor systems 
[25,26]. This discrepancy may be explained by differences between edge-level 
modeling and distance-based modeling of inter-individual differences in the 
connectome. For example, Kebets et al. [26] deployed an edge-level approach testing 
whether dimensions of psychopathology covaried directly with edge strength and 
found that the strongest signals originated from lower-order cortical systems. In 
contrast, identifiability studies effectively score individuals based on the distance 
between their whole-brain connectomes across scans in an N-dimensional space 
(where N denotes the number of edges). Subsequently, covariation with 
psychopathology indexes inter-individual differences in the extent to which 
connectomes are individualized, signals for which appear concentrated in higher-order 
systems [32,33]. This finding suggests that mental disorders affect different parts of the 
cortical hierarchy in qualitatively distinct ways, with edge-level modeling being 
sensitive to lower-order systems that are relatively stable and homogenous across 
people, and the distance-based modeling being sensitive to higher-order systems that 
are highly and increasingly individualized throughout development. 
 
Future directions 
The intersection between transdiagnostic research, dimensional models of 
psychopathology, and connectome development has the potential to uncover novel 
biomarkers in psychiatry. Synthesizing these approaches will require the joint 
application of tools from machine learning and network neuroscience [36]. In particular, 
recent developments in machine learning have provided new tools for modeling, and 
detecting abnormalities in, neurodevelopment [8]. This approach, known as normative 
modeling, involves using Bayesian regression techniques to model the non-linear age-
related changes in neuroimaging data in healthy individuals. Importantly, these 
techniques provide estimates of percentiles of variation within the healthy cohort [9]. In 
contrast to case-control designs, which are restricted to estimating brain abnormalities 
at the group level, these percentiles of variation allow researchers to quantify the 
extent to which patients deviate from the normative age trajectory on an individual 
basis. In psychiatry research, normative models have already been used to illustrate 
the large amount of heterogeneity in brain structure present within disorders such as 
schizophrenia [37], bipolar [37], ADHD [38], and autism [39,40]. These studies have 
shown that few patients, if any, have spatially consistent patterns of age-related brain 
abnormalities, supporting the notion that case-control paradigms provide little utility in 
biomarker detection.  
The extant normative modeling literature has so far focused on indices of brain 
structure, in part because normative models depend upon a robust underlying age 
effect in order to yield interpretable abnormalities. Robust regional age effects are 
trivially obtained using structural indices [41,42] (e.g., gray matter volume), but this is 
not true of edge-level estimates of resting-state functional connectivity. Given the age 
effects reported in the identifiability literature [32,43], normative models may be well 
suited to identifying individual patients with neurodevelopmentally delayed (i.e., 
reduced) connectome individualization (Figure 1). Using pairs of rs-fMRI (or task-based 
fMRI) scans from longitudinal developmental cohorts (Figure 1A), normative models of 
connectome individualization can be estimated in typically developing individuals 
(Figure 1B,  ). Next, deviations can be estimated in a separate cohort (Figure 1B,  ) 
and correlated with dimensional psychopathology models. Such models may assist in 
identifying which axes of psychiatry are associated with the abnormal formation of 
individual connectomes, which may be underpinned by disorganization in higher-order 
brain systems. 
 
 
Figure 1. Abnormally delayed connectome individualization may be characterized 
using a combination of normative modeling and tools from network science. A, 
For each individual, pairs of whole-brain resting-state connectomes may be obtained 
from different scan sessions ( , ). Correlations between connectome-pairs may 
be used to index individualization (e.g., r = 0.7). B, Normative models of age-related 
increases in individualization (  ) can then be specified, and the individual’s deviating 
connectomes (  ) can be further characterized using tools from network science (C, 
D). 
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The issue of biological heterogeneity in psychiatry reveals a clear ‘many to one’ 
problem, where multiple pathophysiological pathways converge on similar forms of 
psychopathology. Thus, normative models of connectome individualization may give 
rise to individuals with quantitatively similar deviations in individualization, and levels of 
psychopathology, that correspond to qualitatively distinct underlying disruptions in 
their connectome architecture. We anticipate that tools from network science will be 
critical to uncovering these unique disruptions [44,45]. For example, brain regions in 
the connectome are organized into functional modules [46] -- characterized by denser 
connectivity within modules than between modules -- and abnormal individualization 
may be reflected in the instability of an individual’s modular structure across scans 
(Figure 1C). Similarly, hub nodes [47,48] -- brain regions whose densely connected 
nature are thought to support the integration of information across functional modules 
-- may be less stable across an individual’s scans (Figure 1D). These examples are not 
exhaustive and we note that many other avenues may also be of interest, including 
developments in the areas of time-varying functional connectivity [49,50] and 
individual-specific parcellations [51–54]. Critically, the nature of an individual’s 
connectome instability, as indexed by network science, need not be the same across 
individuals with similarly high scores on dimensions of psychopathology, 
accommodating the notion that unique patterns of pathophysiology give rise to similar 
symptom profiles. 
 
Conclusions 
While initially fruitful, single disorder case-control studies in psychiatry are unlikely to 
continue to yield advances in biomarker research in the field of psychiatry. Here, we 
briefly discussed recent rs-fMRI work in transdiagnostic psychiatry, dimensional 
psychopathology, and neurodevelopment that we believe are driving the field towards 
more precise biomarkers in mental health. While some differences in methodologies 
remain to be thoroughly examined, results suggest that edge-level and distance-based 
models (i.e., identifiability) yield complementary information relevant to mental health. 
We suggest that combining normative models of connectome individualization with 
transdiagnostic dimensional models of psychopathology and tools from network 
science hold great promise for understanding the link between brain dysfunction and 
mental disorder. 
  
 Box 1 Individuals have unique connectome fingerprints 
 
Studying individual differences in resting-state connectivity has been aided by a shift 
away from the mass-univariate study of edge-level functional connectivity towards 
studying the whole-brain connectome as a single multivariate object. In this context, 
the brain is represented as a symmetric N×N adjacency matrix, A, where N represents 
a number of discrete brain regions referred to as nodes. Within this matrix, elements Aij 
take on a weighted value corresponding to the functional connectivity between nodes i 
and j. This weight can be estimated by a simple Pearson correlation coefficient 
between rs-fMRI timeseries, or by other more sophisticated measures [55]. One 
promising approach for analyzing multivariate inter-individual differences in the 
connectome is known as identifiability. Popularized by Finn et al. [31], identifiability 
involves correlating connectivity estimates within pairs of whole-brain connectomes. 
The simplest setup involves generating at least two whole-brain connectomes for each 
individual in a sample (e.g., across multiple scans/sessions) and then calculating the 
correlation between all possible connectome pairs in a sample. Multiple studies have 
found that correlation coefficients are higher for connectome pairs taken from the 
same individual than for connectome pairs taken across different individuals, allowing 
for the identification of individuals over repeated scans with near perfect accuracy 
[31,56,57]. This phenomenon illustrates that the multivariate pattern of whole brain 
functional connectivity is highly unique to each individual. 
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Highlighted References: 
 
(**) Sha, Z. et al. Meta-Connectomic Analysis Reveals Commonly Disrupted Functional 
Architectures in Network Modules and Connectors across Brain Disorders. Cerebral 
Cortex 28, 4179–4194 (2018). 
 
- This study performed a comprehensive meta-analysis of rs-fMRI connectome 
data and showed that patterns of dysfunction were common across multiple 
psychiatric populations. 
 
 
(**) Li, A. et al. A neuroimaging biomarker for striatal dysfunction in schizophrenia. Nat 
Med 26, 558–565 (2020). 
 
- This study trained a support vector machine to separate patients with 
schizophrenia from healthy controls and showed that their model did not 
generalize to other psychiatric groups, demonstrating disorder-specificity. 
 
 
(**) Kebets, V. et al. Somatosensory-Motor Dysconnectivity Spans Multiple 
Transdiagnostic Dimensions of Psychopathology. Biological Psychiatry 86, 779–791 
(2019). 
 
- This study used partial least squares to demonstrate that dysconnectivity within 
lower-order cortical systems and between lower- and higher-order systems may 
be a common biomarker across many mental disorders. 
 
 
(**) Horien, C., Shen, X., Scheinost, D. & Constable, R. T. The individual functional 
connectome is unique and stable over months to years. NeuroImage 189, 676–687 
(2019). 
 
- This study demonstrated that individual’s unique functional fingerprints were 
stable over months to years, and that higher-order systems drove this 
uniqueness to a greater extent than lower-order systems. 
 
 
(*) Elliott, M. L., Romer, A., Knodt, A. R. & Hariri, A. R. A Connectome-wide Functional 
Signature of Transdiagnostic Risk for Mental Illness. Biological Psychiatry 84, 452–
459 (2018). 
 
- This study combined a dimensional model of psychopathology with 
connectome-wide association analysis to demonstrate that dysconnectivity 
between the visual cortex and higher-order executive systems was associated 
with greater scores on the p-factor. 
 
 
(*) Kaufmann, T. et al. Delayed stabilization and individualization in connectome 
development are related to psychiatric disorders. Nature Neuroscience 20, 513–515 
(2017). 
 
- This study showed that abnormal patterns of connectome distinctiveness 
throughout development was common to multiple mental disorders, and that 
this effect was concentrated in higher-order systems. 
 
 
(*) Marquand, A. F. et al. Conceptualizing mental disorders as deviations from 
normative functioning. Mol Psychiatry (2019). 
 
- This article discusses the concept of identifying abnormal brain signatures on an 
individual rather than a group basis. It provides an overview of the normative 
modeling methodology and how this approach will help to disentangle biological 
heterogeneity in psychiatry. 
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